Skip to main content
U.S. flag

An official website of the United States government

Return to Search

Erythropoietin Stimulating Agents Policies

Guidance for Erythropoietin Stimulating Agents in ESRD facilities.

Final

Issued by: Centers for Medicare & Medicaid Services (CMS)

Issue Date: January 30, 2020

CMS has policies that effect the use of Erythropoietin Stimulating Agents in ESRD facilities. To find out more, click on the links below.

HHS is committed to making its websites and documents accessible to the widest possible audience, including individuals with disabilities. We are in the process of retroactively making some documents accessible. If you need assistance accessing an accessible version of this document, please reach out to the guidance@hhs.gov.

DISCLAIMER: The contents of this database lack the force and effect of law, except as authorized by law (including Medicare Advantage Rate Announcements and Advance Notices) or as specifically incorporated into a contract. The Department may not cite, use, or rely on any guidance that is not posted on the guidance repository, except to establish historical facts.